The Norwegian Institute of Public Health (henceforth referred to as FHI) has on behalf of the Ministry of Health and Care Services conducted a competitive dialogue for procurement of pandemic influenza vaccine to the Norwegian population. The purpose of the procurement is to ensure that the inhabitants of Norway have access to vaccine in case of a possible pandemic influenza throughout the agreement period.

The awarded contracts will contain an option for delivery of pandemic influenza vaccine in the agreement period The viral components must be in accordance with the recommendations made by the WHO. The total volume shall cover full immunization of up to 5 000 000 — 5 500 000 people (the Norwegian population at the time of delivery). The number of doses ordered by the FHI from each supplier in case of an outbreak will be dependent on the chosen immunization regime and the expected severity of the pandemic.